PNC extends Integrated BioPharma (INBP) line of credit to July 2026
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Integrated BioPharma, Inc. reported that PNC Bank extended the expiration date of its line of credit, documented in an April 15, 2025 promissory note, from April 15, 2026 to July 14, 2026. The extension, which also covers subsidiary Manhattan Drug Company, Inc., becomes effective on April 16, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Notification date: April 14, 2026
Original expiration date: April 15, 2026
New expiration date: July 14, 2026
+1 more
4 metrics
Notification date
April 14, 2026
Date PNC notified the companies of the extension
Original expiration date
April 15, 2026
Initial expiration date of the line of credit
New expiration date
July 14, 2026
Extended expiration date of the line of credit
Effective date of extension
April 16, 2026
Date on which the extension becomes effective
Key Terms
Line of Credit, promissory note, Emerging growth company, Other Events
4 terms
Line of Credit financial
"the Companies' Expiration Date of the Line of Credit with PNC"
A line of credit is a flexible borrowing arrangement that lets a company draw money up to a preset limit, repay it, and borrow again as needed—similar to a business credit card or an emergency tap on a savings account. It matters to investors because it shows how a firm manages short-term cash needs and growth funding without taking a single large loan; access, cost, and attached conditions can affect liquidity, interest expenses and financial risk.
promissory note financial
"as set forth in a promissory note executed and delivered"
A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Other Events regulatory
"8.01 Other Events. On April 14, 2026, Integrated BioPharma, Inc."
FAQ
What did Integrated BioPharma (INBP) disclose in its latest 8-K?
Integrated BioPharma disclosed that PNC Bank extended the expiration date of its line of credit from April 15, 2026 to July 14, 2026. The change applies to the company and its subsidiary Manhattan Drug Company, Inc. and becomes effective on April 16, 2026.
Which lender extended Integrated BioPharma (INBP)’s line of credit?
The line of credit for Integrated BioPharma and its subsidiary is with PNC Bank, National Association. PNC notified the companies on April 14, 2026 that the expiration date was being extended, with the extension effective on April 16, 2026.
How long was Integrated BioPharma (INBP)’s credit line extended?
The expiration date of Integrated BioPharma’s line of credit was extended from April 15, 2026 to July 14, 2026. PNC Bank also allowed for a later date to be designated at its sole discretion by written notice to the companies.
When does the extension of Integrated BioPharma (INBP)’s credit line take effect?
The extension of the line of credit’s expiration date becomes effective on April 16, 2026. This change modifies the original April 15, 2026 expiration and now runs through July 14, 2026, unless PNC designates a later date in writing.
Which subsidiaries of Integrated BioPharma (INBP) are covered by the credit line?
The credit line extension applies to Integrated BioPharma, Inc. and Manhattan Drug Company, Inc. Manhattan Drug Company is a wholly owned subsidiary, and together they are the borrowers under the April 15, 2025 promissory note with PNC Bank.